ASCEND BY NTHRYS
Research Abroad Products

Gene Fusion Project Topics

Browse all focused areas across all project categories under this field.

Showing 109–120 of 200 project topics
Liquid Biopsy Fusion Testing Marketplace Platform
Digital marketplace connecting oncologists, hospitals, and patients directly with accredited fusion testing providers and enabling sample logistics coordination. Captures 15-25% transaction fees on $2,000-$4,000 average test value with potential for 10,000+ monthly tests generating $30M-$100M annual revenue.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Next-Generation Sequencing Fusion Data Analytics Toolkit
Specialized commercial toolkit that processes NGS data from liquid biopsy to detect, validate, and visualize gene fusion events with superior sensitivity and specificity. Sold through enterprise software licensing, integration partnerships with sequencing platforms, and OEM agreements worth $250K-$2M per partner annually.
Liquid Biopsy Gene Fusion Platform Dev Click to view more details →
Real-time Gene Fusion Detection SaaS Platform
A cloud-based software platform that identifies and classifies gene fusion events from RNA-seq data in minutes using proprietary algorithms. Enables clinical labs and pharmaceutical companies to accelerate diagnostic turnaround time and charge premium fees for rapid fusion detection services.
RNA Fusion Analytics Technology Platform Click to view more details →
Oncology-focused Fusion Transcript Annotation Tool
A specialized bioinformatics tool that automatically annotates cancer-related RNA fusion transcripts and predicts their functional impact on protein translation. Generates licensing revenue from cancer research institutes and diagnostic laboratories seeking FDA-compliant fusion reporting capabilities.
RNA Fusion Analytics Technology Platform Click to view more details →
Enterprise Grade Multi-Sample Fusion Analysis Software
Scalable software solution processing thousands of RNA samples simultaneously to detect fusion events across diverse cancer types and tissue origins. Delivers recurring SaaS revenue through institutional subscriptions from cancer centers, biobanks, and contract research organizations.
RNA Fusion Analytics Technology Platform Click to view more details →
AI-powered False Positive Elimination Validation Engine
Machine learning platform that uses deep learning models to distinguish true gene fusions from sequencing artifacts and alignment errors in RNA data. Reduces validation costs for laboratories and creates premium tier services commanding higher per-sample pricing.
RNA Fusion Analytics Technology Platform Click to view more details →
Clinical Grade Fusion-Targeted Therapy Recommendation System
Decision support platform integrating detected gene fusions with curated databases of targeted therapies and clinical trials to guide treatment selection. Monetizes through institutional licensing, pharmaceutical partnerships, and integration fees from electronic health record systems.
RNA Fusion Analytics Technology Platform Click to view more details →
Liquid Biopsy Circulating Tumor DNA Fusion Detection Kit
Commercial diagnostic assay kit detecting gene fusions directly from blood-derived circulating tumor DNA using optimized RNA capture and sequencing protocols. Generates high-margin consumable revenue by targeting non-invasive cancer screening and minimal residual disease monitoring markets.
RNA Fusion Analytics Technology Platform Click to view more details →
Regulatory Compliant Fusion Reporting Automation Platform
Cloud application automatically generates FDA and CAP-accredited clinical reports for detected gene fusions with standardized nomenclature and evidence citations. Delivers SaaS revenue while reducing clinical laboratory staff time and enabling scalable expansion of fusion testing services.
RNA Fusion Analytics Technology Platform Click to view more details →
Custom Reference Database Integration and Curation Service
Professional services offering that integrates client-specific gene fusion databases with existing analysis platforms and maintains regular literature-based updates. Creates recurring professional services revenue while increasing platform stickiness and customer switching costs.
RNA Fusion Analytics Technology Platform Click to view more details →
Cross-Cancer Fusion Biomarker Discovery and Validation Platform
Research platform enabling pharmaceutical and biotech companies to identify novel fusion biomarkers associated with drug response across cancer cohorts. Monetizes through research partnership agreements, milestone payments from pharma collaborators, and data licensing arrangements.
RNA Fusion Analytics Technology Platform Click to view more details →
Portable RNA Fusion Detection Mobile Lab Solution
Integrated hardware and software system enabling on-site gene fusion analysis at remote clinical facilities without centralized laboratory infrastructure. Opens new revenue streams from underserved geographic markets, telehealth providers, and precision oncology centers.
RNA Fusion Analytics Technology Platform Click to view more details →